IBO
Impact BioMedical, Inc.
AMEX: IBO · HEALTHCARE · BIOTECHNOLOGY
$0.66
-2.59% today
Updated 2026-05-01
Market cap
$71.16M
P/E ratio
—
P/S ratio
2,223.81x
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$0 – $2
Volume
5.4M
WallStSmart proprietary scores
15
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D4.5
Quality
C2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-3.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $99000.00 — positive
+ Debt/equity -1.94x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -3.39 — distress zone
- Thin margins at 0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $50000.00 | $1.03M | $2.33M | $32000.00 | $32000.00 |
| Net income | $-7.05M | $-4.34M | $-2.05M | $-11.84M | $5.25M |
| EPS | — | — | — | — | $-0.38 |
| Free cash flow | $-4.43M | $-2.87M | $-5.64M | $-1.89M | $99000.00 |
| Profit margin | -14,102.00% | -420.98% | -88.01% | -36,993.75% | — |
Peer comparison
Smart narrative
Impact BioMedical, Inc. trades at $0.66. Our Smart Value Score of 15/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -3.39, it sits in the distress. TTM revenue stands at $32000.00.
Frequently asked questions
What is Impact BioMedical, Inc.'s stock price?
Impact BioMedical, Inc. (IBO) trades at $0.66.
Is Impact BioMedical, Inc. overvalued?
Smart Value Score 15/100 (Grade F, Strong Sell).
What is the price target of Impact BioMedical, Inc. (IBO)?
The analyst target price is $—, representing NaN% downside from the current price of $0.66.
What is Impact BioMedical, Inc.'s revenue?
TTM revenue is $32000.00.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-3.39 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeAMEX
CurrencyUSD
Quick metrics
P/S ratio2,223.81x
ROE-104.20%
Beta—
50D MA$0.57
200D MA$0.56
Shares out0.11B
Float0.01B
Short ratio—
Avg volume5.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—